Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label Single-center Trial of Lipo-prostaglandin E1 Improves Coronary Microcirculation Dysfunction in Patients With Ischemic Heart Disease Combine With Diabetes Mellitus

NCT03159559 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03159559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label Single-center Trial of Lipo-prostaglandin E1 Improves Coronary Microcirculation Dysfunction in Patients With Ischemic Heart Disease Combine With Diabetes Mellitus
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
March 31, 2018
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular perfusion in patients with ischemic heart disease